Trade ALX Oncology Holdings Inc. - ALXO CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.05 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023374% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001151% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 50.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 1.45 |
| Open | 1.55 |
| 1-Year Change | -88.9% |
| Day's Range | 1.51 - 1.64 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Dec 20, 2024 | 1.58 | 0.08 | 5.33% | 1.50 | 1.64 | 1.49 |
| Dec 19, 2024 | 1.45 | -0.30 | -17.14% | 1.75 | 1.79 | 1.45 |
| Dec 18, 2024 | 1.82 | 0.05 | 2.82% | 1.77 | 2.02 | 1.67 |
| Dec 17, 2024 | 1.78 | 0.27 | 17.88% | 1.51 | 1.86 | 1.50 |
| Dec 16, 2024 | 1.52 | 0.08 | 5.56% | 1.44 | 1.57 | 1.41 |
| Dec 13, 2024 | 1.43 | 0.04 | 2.88% | 1.39 | 1.49 | 1.39 |
| Dec 12, 2024 | 1.40 | -0.09 | -6.04% | 1.49 | 1.59 | 1.37 |
| Dec 11, 2024 | 1.49 | -0.07 | -4.49% | 1.56 | 1.57 | 1.49 |
| Dec 10, 2024 | 1.55 | -0.10 | -6.06% | 1.65 | 1.66 | 1.54 |
| Dec 9, 2024 | 1.69 | 0.06 | 3.68% | 1.63 | 1.77 | 1.63 |
| Dec 6, 2024 | 1.60 | -0.20 | -11.11% | 1.80 | 1.81 | 1.58 |
| Dec 5, 2024 | 1.79 | 0.22 | 14.01% | 1.57 | 1.84 | 1.57 |
| Dec 4, 2024 | 1.53 | -0.01 | -0.65% | 1.54 | 1.65 | 1.50 |
| Dec 3, 2024 | 1.53 | -0.11 | -6.71% | 1.64 | 1.78 | 1.52 |
| Dec 2, 2024 | 1.63 | 0.16 | 10.88% | 1.47 | 1.66 | 1.45 |
| Nov 29, 2024 | 1.46 | -0.05 | -3.31% | 1.51 | 1.53 | 1.43 |
| Nov 27, 2024 | 1.48 | -0.02 | -1.33% | 1.50 | 1.50 | 1.45 |
| Nov 26, 2024 | 1.46 | -0.01 | -0.68% | 1.47 | 1.52 | 1.44 |
| Nov 25, 2024 | 1.45 | 0.05 | 3.57% | 1.40 | 1.57 | 1.40 |
| Nov 22, 2024 | 1.39 | 0.13 | 10.32% | 1.26 | 1.42 | 1.25 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 20
- 100
- 500
- 1000
- 10000
ALX Oncology Holdings Inc. Company profile
About ALX Oncology Holdings Inc
ALX Oncology Holdings Inc. is a clinical-stage immuno-oncology company. The Company is focused on enabling patients to fight cancer by developing therapies that block the cluster of differentiation 47 (CD47) checkpoint pathway and bridge the innate and adaptive immune system. The Company is developing a checkpoint inhibitor designed to have an affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches. Its lead product candidate, ALX148, is a CD47 blocking therapeutic. ALX148 is a fusion protein that combines a CD47 binding domain with its inactivated fragment crystallizable (Fc) domain. The CD47 binding domain of ALX148 is an affinity enhanced extracellular domain of signal regulatory protein alpha (SIRPa), a protein that is the natural receptor to CD47 found on myeloid cells. Its programs are focused on targeting CD47 across various oncology indications.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, ALX Oncology Holdings Inc revenues decreased from $1.2M to $0K. Net loss applicable to common stockholders increased 64% to $83.5M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Reserach and developement increase of 76% to $46.5M (expense).
| Industry: | Bio Therapeutic Drugs |
323 Allerton Avenue
SOUTH SAN FRANCISCO
CALIFORNIA 94080
US
News
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
22:39, 12 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024
Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024
Dogecoin (DOGE) price prediction 2025-2030: Could Dogecoin reach $1? - Third party price target
We look at the meme coin’s price performance and the latest DOGE price predictions
08:37, 12 December 2024
Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
09:13, 6 December 2024
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
12:47, 5 December 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com